eMedicine Specialties > Hematology > Red Blood Cells and Disorders

Iron Deficiency Anemia: Follow-up

Author: Marcel E Conrad, MD, (Retired) Distinguished Professor of Medicine, University of South Alabama
Contributor Information and Disclosures

Updated: Aug 4, 2009

Follow-up

Further Outpatient Care

  • Monitor patients with iron deficiency anemia on an outpatient basis to ensure that there is an adequate response to iron therapy and that iron therapy is continued until after correction of the anemia to replenish body iron stores. Follow-up also may be important to treat any underlying cause of the iron deficiency.
  • Response to iron therapy can be documented by an increase in reticulocytes 5-10 days after the initiation of iron therapy. The hemoglobin concentration increases about 1 g/dL weekly until normal values are restored. These responses are blunted in the presence of sustained blood loss or coexistent factors that impair hemoglobin synthesis.

Transfer

Transfer of a patient rarely is required for treatment of simple iron deficiency anemia; however, it may be necessary to identify the etiology of the anemia, such as occult blood loss undetected with chemical testing of stool specimens, for identification of a source of bleeding that requires endoscopic examinations or angiography or for treatment of an underlying major illness (eg, neoplasia, ulcerative colitis).

Deterrence/Prevention

  • Certain populations are at sufficiently high risk of iron deficiency to warrant consideration for prophylactic iron therapy. These include pregnant women, women with menorrhagia, consumers of a strict vegetarian diet, infants, adolescent females, and regular blood donors.
  • Pregnant women have been given supplemental iron since World War II. Often, this is administered in all-purpose capsules containing vitamins, calcium, and iron. If the patient is anemic (hemoglobin <11 g/dL), administer the iron at a different time of day than calcium because calcium inhibits iron absorption. The practice of routinely administering iron to pregnant females in affluent societies has been challenged recently; however, provide prophylactic iron therapy during the last one half of pregnancy, except in settings where careful follow-up for anemia and methods for measurement of serum iron and ferritin are readily available.
  • Iron supplementation of the diet of infants is advocated. Premature infants require more iron supplementation than term infants. Infants weaned early and fed bovine milk require more iron because the higher concentration of calcium in cow milk inhibits absorption of iron. Usually, infants receive iron from fortified cereal. Additional iron is present in commercial milk formulas.
  • Iron supplementation in populations living on a largely vegetarian diet is advisable because of the lower bioavailability of inorganic iron than heme iron.

Complications

  • Iron deficiency anemia diminishes work performance by forcing muscles to depend, to a greater extent than in healthy individuals, upon anaerobic metabolism. This is believed to be due to deficiency in iron-containing respiratory enzymes rather than anemia.
  • Severe anemia due to any cause may produce hypoxemia and enhance the occurrence of coronary insufficiency and myocardial ischemia. Likewise, it can worsen the pulmonary status of patients with chronic pulmonary disease.
  • Defects in structure and function of epithelial tissues may be observed in iron deficiency. Fingernails may become brittle or longitudinally ridged with development of koilonychia (spoon-shaped nails). The tongue may show atrophy of the lingual papillae and develop a glossy appearance. Angular stomatitis may occur with fissures at the corners of the mouth. Dysphagia may occur with solid foods, with webbing of the mucosa at the junction of the hypopharynx and the esophagus (Plummer-Vinson syndrome); this has been associated with squamous cell carcinoma of the cricoid area. Atrophic gastritis occurs in iron deficiency with progressive loss of acid secretion, pepsin, and intrinsic factor and development of an antibody to gastric parietal cells. Small intestinal villi become blunted.
  • Cold intolerance develops in one fifth of patients with chronic iron deficiency anemia and is manifested by vasomotor disturbances, neurologic pain, or numbness and tingling.
  • Rarely, severe iron deficiency anemia is associated with papilledema, increased intracranial pressure, and the clinical picture of pseudotumor cerebri. These manifestations are corrected with iron therapy.
  • Impaired immune function is reported in subjects who are iron deficient, and there are reports that these patients are prone to infection; however, evidence that this is directly due to iron deficiency is not convincing because of the presence of other factors.
  • Children deficient in iron may exhibit behavioral disturbances. Neurologic development is impaired in infants and scholastic performance is reduced in children of school age. The IQ of school children deficient in iron is reported as significantly less than their nonanemic peers. Behavioral disturbances may manifest as an attention deficit disorder. Growth is impaired in infants with iron deficiency. All these manifestations improve following iron therapy.

Prognosis

Iron deficiency anemia is an easily treated disorder with an excellent outcome; however, it may be caused by an underlying condition with a poor prognosis, such as neoplasia. Similarly, the prognosis may be altered by a comorbid condition such as coronary artery disease.

Patient Education

  • Physician education is needed to ensure a greater awareness of iron deficiency and the testing needed to establish the diagnosis properly. Physician education also is needed to investigate the etiology of the iron deficiency.
  • Public health officials in geographic regions where iron deficiency is prevalent need to be aware of the significance of iron deficiency, its effect upon work performance, and the importance of providing iron during pregnancy and childhood. The addition of iron to basic foodstuffs is employed in these areas to diminish the problem.
  • For excellent patient education resources, visit eMedicine's Blood and Lymphatic System Center and Esophagus, Stomach, and Intestine Center. Also, see eMedicine's patient education articles Anemia and Celiac Sprue.

Miscellaneous

Medicolegal Pitfalls

  • Failure to investigate the etiology of the iron deficiency anemia causing a delayed or missed diagnosis of neoplasm
  • Giving iron to patients who have a microcytic iron-overloading disorder (eg, thalassemia, sideroblastic anemia)
  • Failure to promptly and adequately treat a patient with iron deficiency anemia who is symptomatic with a comorbid condition such as coronary artery disease
  • Anaphylaxis pursuant to the use of parenteral iron therapy in patients who should be treated with oral iron

Special Concerns

  • Special effort should be made to identify and treat iron deficiency during pregnancy and early childhood because of the effects of severe iron deficiency upon learning capability, growth, and development.
  • The addition of iron to basic foodstuffs in affluent nations where meat is an important part of the diet is of questionable value and may be harmful. The gene for familial hemochromatosis (HFe gene) is prevalent (8% of US white population). Excess body iron is postulated to be important in the etiology of coronary artery disease, strokes, certain carcinomas, and neurodegenerative disorders because iron is important in free radical formation.
 


More on Iron Deficiency Anemia

Overview: Iron Deficiency Anemia
Differential Diagnoses & Workup: Iron Deficiency Anemia
Treatment & Medication: Iron Deficiency Anemia
Follow-up: Iron Deficiency Anemia
Multimedia: Iron Deficiency Anemia
References

References

  1. Mateos Gonzalez ME, de la Cruz Bertolo J, Lopez Laso E, Valdes Sanchez MD, Nogales Espert A. [Review of haematology and biochemistry parameters to identify iron deficiency] [Spanish]. An Pediatr (Barc). Aug 2009;71(2):95-102. [Medline][Full Text].

  2. Beutler E, Lichtman MA, Coller BS. Williams Hematology. 6th ed. New York, NY: McGraw-Hill Book Co; 2001:295-304, 447-70.

  3. Bothwell TH, Charlton RW, Cook JD. Iron Metabolis in Man. 1979:1-77.

  4. Conrad ME, Umbreit JN. Iron absorption and transport-an update. Am J Hematol. Aug 2000;64(4):287-98. [Medline].

  5. Hoffman R, Benz EJ Jr, Shattil SJ. Hematology: Basic Principles and Practice. Vol 3. New York, NY: Churchill Livingston; 1998:397-427.

  6. Lee GR, Foerster J, Lukens J. Wintrobe's Clinical Hematology. Vol 10. 10th ed. Baltimore, Md: Williams & Wilkins; 1999:979-1011.

  7. McLoughlin MT, Tham TC. Long-term follow-up of patients with iron deficiency anaemia after a negative gastrointestinal evaluation. Eur J Gastroenterol Hepatol. Aug 2009;21(8):872-6. [Medline].

Further Reading

Keywords

sideropenia, posthemorrhagic anemia, erythropoiesis, hemosiderosis, sprue, celiac disease, regional enteritis, ferric iron, ferrous iron, small bowel disease, regional enteritis, previous gastrointestinal surgery, intestinal parasites, hookworms,

gastrointestinal neoplasms, gastrointestinal bleeding, pica eating, clay eating, starch eating, hematuria, hematemesis, hemoptysis, hemorrhage, melanotic stool, pagophagia, leg cramps, dysphagia with esophageal webbing, koilonychia, glossitis, angular stomatitis, gastric atrophy, atrophic changes of the tongue, splenomegaly, phytates, oxalates, phosphates,

carbonates, tannates, hemosiderinuria, hemoglobinuria, pulmonary hemosiderosis, paroxysmal nocturnal hemoglobinuria, brisk intravascular hemolytic anemia, prolonged achlorhydria, celiac syndrome, sex-linked anemia, microcytic anemia, metabolic processes

Contributor Information and Disclosures

Author

Marcel E Conrad, MD, (Retired) Distinguished Professor of Medicine, University of South Alabama
Marcel E Conrad, MD is a member of the following medical societies: Alpha Omega Alpha, American Association for the Advancement of Science, American Association of Blood Banks, American Chemical Society, American College of Physicians, American Physiological Society, American Society for Clinical Investigation, American Society of Hematology, Association of American Physicians, Association of Military Surgeons of the US, International Society of Hematology, Society for Experimental Biology and Medicine, and Southwest Oncology Group
Disclosure: No financial interests None None

Medical Editor

Paul Schick, MD, Emeritus Professor, Department of Internal Medicine, Thomas Jefferson University Medical College; Research Professor, Department of Internal Medicine, Drexel University College of Medicine; Adjunct Professor of Medicine, Lankenau Hospital, Wynnewood, PA
Paul Schick, MD is a member of the following medical societies: American College of Physicians, American Heart Association, American Society of Hematology, International Society on Thrombosis and Haemostasis, and New York Academy of Sciences
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Ronald A Sacher, MB, BCh, MD, FRCPC, Professor, Internal Medicine and Pathology, Director, Hoxworth Blood Center, University of Cincinnati Academic Health Center
Ronald A Sacher, MB, BCh, MD, FRCPC is a member of the following medical societies: American Society of Hematology
Disclosure: Glaxo Smith Kline Honoraria Speaking and teaching; Talecris Honoraria Board membership

CME Editor

Rajalaxmi McKenna, MD, FACP, Consulting Staff, Department of Medicine, Southwest Medical Consultants, SC, Good Samaritan Hospital, Advocate Health Systems
Rajalaxmi McKenna, MD, FACP is a member of the following medical societies: American Society of Clinical Oncology, American Society of Hematology, and International Society on Thrombosis and Haemostasis
Disclosure: Nothing to disclose.

Chief Editor

Emmanuel C Besa, MD, Professor, Department of Medicine, Division of Hematologic Malignancies, Kimmel Cancer Center, Thomas Jefferson University
Emmanuel C Besa, MD is a member of the following medical societies: American Association for Cancer Education, American College of Clinical Pharmacology, American Federation for Medical Research, American Society of Hematology, and New York Academy of Sciences
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.